Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 207, member B, pseudogene (FAM207BP) is a pseudogene-derived long non-coding RNA, not encoding a protein product. It has no known function as a receptor, enzyme, or classical drug target. FAM207BP is significantly overexpressed in lung adenocarcinoma tissues compared to normal tissues, with its expression correlated with increased cancer cell proliferation, migration, and invasion. Lower expression is associated with greater immune cell (B cell) infiltration, suggesting it may influence tumor immunity. Its function is largely restricted to gene expression regulation and cancer cell biology, with current data supporting its use as a prognostic biomarker in specific cancers rather than as a direct therapeutic target[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 207, member B, pseudogene (FAM207BP).